Mylan’s Famy Care Affair May Culminate In Buyout
This article was originally published in PharmAsia News
Executive Summary
Mylan is seen as an aggressive buyer of businesses in India. After signing a series of acquisitions that bolstered its manufacturing capabilities, the company is now moving closer to a deal with Famy Care, its long-time partner for oral contraceptives.